A liaison-clinical pathway for patients with stageI to III gastric cancer after curative operation has been introduced and managed in our hospital from July 2009. We made two kinds of liaison-clinical pathway in the presence or absence of postoperative adjuvant therapy. The duration of follow-up was 5 years in proportion to the Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach. We held a briefing session for practicing physicians involved after liaison-clinical pathway making, conducted a questionnaire, and judged whether induction was possible. The liaison-clinical pathway consists of a chart for practicing physicians, leaflets with checklists for the patients, and other documents. We began to use them in July, 2009, and involved patients are 11 to date. Because postoperative treatment planning became clear by using the liaison-clinical pathway, we were able to relieve the anxiety of patients with cancer, and it seemed that it was easy to facilitate to perform cancer cooperation by the practicing physicians. For the introduction and management of this pathway, a thorough explanation to the patients with gastric cancer and good communication is required with the practicing physicians in cooperation with the coordinator.

Download full-text PDF

Source

Publication Analysis

Top Keywords

liaison-clinical pathway
24
practicing physicians
16
gastric cancer
12
pathway patients
8
patients gastric
8
cancer curative
8
july 2009
8
pathway
7
liaison-clinical
6
patients
6

Similar Publications

Article Synopsis
  • The hospital became a designated cancer care facility in Osaka in April 2012 and implemented a specific clinical pathway for cancer patients post-surgery.
  • They identified several issues with the pathway, including lack of awareness, complexity, patient confusion, and poor understanding among doctors.
  • To address these challenges, the hospital introduced five measures, such as increasing public information and improving consent processes, which helped enhance the effectiveness of the clinical pathway over time.
View Article and Find Full Text PDF

We retrospectively examined the feasibility and outcome of S-1 adjuvant chemotherapy for 18 patients with gastric cancer treated based on the liaison-clinical pathway (liaison group), and compared them with those of 26 patients treated before the induction of the liaison-clinical pathway (non-liaison group). The persistent rate of S-1 adjuvant chemotherapy for one year except for recurrence, the relative performance (RP) value of cases who had received S-1 for one year, and Grade 3/4 adverse events in non-liaison group/liaison group, were 88.5/87.

View Article and Find Full Text PDF

[Present and future of tuberculosis care in regions].

Kekkaku

December 2012

National Hospital Organization Higashihiroshima Medical Center, 513 Jike, Saijo-cho, Higashihiroshima-shi, Hiroshima 739-0041 Japan.

As the incidence of active tuberculosis in Japan declines and the healthcare environment changes, restructuring of the medical care system for tuberculosis is required. According to a questionnaire survey in Hiroshima Prefecture, experiences in tuberculosis (TB) care and knowledge, such as standard treatment and DOT, is insufficient in the local medical institutions designated for tuberculosis care. Regional coordination between the tuberculosis hospital and the regional private practitioners will be one of the important issues in proper TB care.

View Article and Find Full Text PDF
Article Synopsis
  • - The evaluation of a clinical pathway for breast cancer patients, implemented in May 2008, involved data from a survey of 56 clinics and 105 patients, showing that 93% of physicians found it useful.
  • - While only 24% of physicians fully utilized the pathway, 40% of clinics aimed to increase patient numbers and available treatments.
  • - Among patients, 55% found the pathway helpful, but only 29% consistently used the patient booklet, and 8% reported complaints to the clinics, indicating overall satisfaction but highlighting areas for improvement in electronic health records and patient responsiveness.
View Article and Find Full Text PDF

A liaison-clinical pathway for patients with stageI to III gastric cancer after curative operation has been introduced and managed in our hospital from July 2009. We made two kinds of liaison-clinical pathway in the presence or absence of postoperative adjuvant therapy. The duration of follow-up was 5 years in proportion to the Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!